Patent ID: 6930125

Claim:
A method for enhancing the therapeutic efficacy of one or more agents, selected from the group consisting of albuterol, levalbuterol HCl and ipratroprium bromide, used in the treatment of one or more airway diseases selected from the group consisting of asthma, asthma exacerbations, smooth muscle constriction, airway inflammation, overproduction of mucus, human rhinovirus infection, common cold, allergic rhinitis, tuberculosis, cough, wheeze and airtrapping, said method comprising combining at least one non-toxic, alkaline composition, selected from the group consisting of acetate salts, ammonium salts phosphate salts, bicarbonate salts, glycine and glutamine, in a nebulized form with said conventional agent immediately prior to bringing the resulting combination into contact with a patient's airways such that the resulting combination has a pH of at least 7.4 and no more than 10.0.